The genomic architecture of antimalarial drug resistance
Tags:
Reference:
Briefings in Functional Genomics, Volume 18, Issue 5, September 2019, Pages 314–328
Plasmodium falciparum and Plasmodium vivax, the two protozoan parasite species that cause the majority of cases of human malaria, have developed resistance to nearly all known antimalarials. The ability of malaria parasites to develop resistance is primarily due to the high numbers of parasites in the infected person’s bloodstream during the asexual blood stage of infection in conjunction with the mutability of their genomes.